FA
STJ

FDx Advisors’s St Jude Medical STJ Stock Holding History

FDx Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,193
Closed -$561K – 984
2016
Q2 		$561K Buy
+7,193
New +$513K 0.03% 560
2015
Q3 		– Sell
-6,601
Closed -$482K – 948
2015
Q2 		$482K Sell
6,601
-499
-7% -$36K 0.02% 592
2015
Q1 		$466K Buy
7,100
+694
+11% +$46.1K 0.01% 985
2014
Q4 		$417K Buy
6,406
+218
+4% +$14K 0.03% 609
2014
Q3 		$372K Buy
+6,188
New +$404K 0.02% 703
2014
Q2 		– Sell
-5,616
Closed -$367K – 1005
2014
Q1 		$367K Buy
5,616
+828
+17% +$53.9K 0.03% 542
2013
Q4 		$297K Buy
+4,788
New +$277K 0.03% 531

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

FDx Advisors's STJ Position: Q3 2016 in Review

FDx Advisors sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 7,193 shares — an estimated $561K sold.

FDx Advisors first reported a position in STJ in Q4 2013 and held it in 7 quarters. The position peaked at $561K in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • FDx Advisors reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • FDx Advisors sold 7,193 St Jude Medical shares in Q3 2016, an estimated $561K.
  • FDx Advisors first reported a position in St Jude Medical in Q4 2013 and held it in 7 quarters.
  • FDx Advisors's St Jude Medical position peaked at $561K in Q2 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on FDx Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.